UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Trend and treatment patterns of aplastic anemia in Korea, pure red cell aplasia and myelodysplastic syndrome in Korea: a nation-wide analysis

International journal of hematology, 2017-10, Vol.106 (4), p.500-507

2017

Volltextzugriff (PDF)

Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study

Haematologica (Roma), 2016-06, Vol.101 (6), p.717-723

2016

Volltextzugriff (PDF)

Survey of Opioid Risk Tool Among Cancer Patients Receiving Opioid Analgesics

Journal of Korean Medical Science, 2022, 37(23), , pp.1-11

2022

Volltextzugriff (PDF)

High level of pre-treatment C-reactive protein to albumin ratio predicts inferior prognosis in diffuse large B-cell lymphoma

Scientific reports, 2021-01, Vol.11 (1), p.2674-2674, Article 2674

2021

Volltextzugriff (PDF)

Pretreatment C-reactive protein-to-albumin ratio predicts clinical outcomes in patients with peripheral T-cell lymphoma

International journal of hematology, 2023-02, Vol.117 (2), p.216-224

2023

Volltextzugriff (PDF)

The efficacy of pemetrexed as a third- or fourth-line therapy and the significance of thymidylate synthase expression in patients with advanced non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2010-09, Vol.69 (3), p.323-329

2010

Volltextzugriff (PDF)

Clinical impact of amphiregulin expression in patients with epidermal growth factor receptor (EGFR) wild‐type nonsmall cell lung cancer treated with EGFR‐tyrosine kinase inhibitors

Cancer, 2011-01, Vol.117 (1), p.143-151

2011

Volltextzugriff (PDF)

Change of health-related profiles after Imatinib cessation in chronic phase chronic myeloid leukemia patients

Leukemia & lymphoma, 2016-02, Vol.57 (2), p.341-347

2016

Volltextzugriff (PDF)

Single cell proteogenomic sequencing identifies a relapse‐fated AML subclone carrying FLT3‐ITD with CN‐LOH at chr13q

EJHaem, 2022-05, Vol.3 (2), p.426-433

2022

Volltextzugriff (PDF)

Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)

Cancer chemotherapy and pharmacology, 2011-09, Vol.68 (3), p.753-761

2011

Volltextzugriff (PDF)

High-Dose Ifosfamide as Second- or Third-Line Chemotherapy in Refractory Bone and Soft Tissue Sarcoma Patients

Oncology, 2011-01, Vol.80 (3-4), p.257-261

2011

Volltextzugriff (PDF)

Lenalidomide for anemia correction in lower-risk del(5q) myelodysplastic syndrome patients of Asian ethnicity

Blood Research, 2021, 56(2), , pp.102-108

2021

Volltextzugriff (PDF)

Comparison of Therapeutic Outcomes Between Surgical Resection Followed By R-CHOP and R-CHOP Alone for Localized Primary Intestinal Diffuse Large B-cell Lymphoma

American journal of clinical oncology, 2014-04, Vol.37 (2), p.182-187

2014

Volltextzugriff (PDF)

Can upfront systemic chemotherapy replace stereotactic radiosurgery or whole brain radiotherapy in the treatment of non-small cell lung cancer patients with asymptomatic brain metastases?

Lung cancer (Amsterdam, Netherlands), 2010-05, Vol.68 (2), p.258-263

2010

Volltextzugriff (PDF)

Real‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis

Cancer communications (London, England), 2021-03, Vol.41 (3), p.275-278

2021

Volltextzugriff (PDF)

Anti-erythropoietin and anti-thrombopoietin antibodies induced after administration of recombinant human erythropoietin

International immunopharmacology, 2011-12, Vol.11 (12), p.2237-2241

2011

Volltextzugriff (PDF)

Clinical significance of a serum CA15-3 surge and the usefulness of CA15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer

Breast cancer research and treatment, 2009-11, Vol.118 (1), p.89-97

2009

Volltextzugriff (PDF)

Irinotecan monotherapy as second-line treatment in advanced pancreatic cancer

Cancer chemotherapy and pharmacology, 2009-05, Vol.63 (6), p.1141-1145

2009

Volltextzugriff (PDF)

Excision repair cross‐complementation group 1 (ERCC1) expression in advanced urothelial carcinoma patients receiving cisplatin‐based chemotherapy

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2010-12, Vol.118 (12), p.941-948

2010

Volltextzugriff (PDF)

Clinical impact of K-ras mutation in colorectal cancer patients treated with adjuvant FOLFOX

Cancer chemotherapy and pharmacology, 2011-08, Vol.68 (2), p.317-323

2011

Volltextzugriff (PDF)

Prognostic role of insulin-like growth factor receptor-1 expression in small cell lung cancer

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2009-12, Vol.117 (12), p.861-869

2009

Volltextzugriff (PDF)

Outcomes of third-line docetaxel-based chemotherapy in advanced gastric cancer who failed previous oxaliplatin-based and irinotecan-based chemotherapies

Cancer Research and Treatment, 2012, 44(4), , pp.235-241

2012

Volltextzugriff (PDF)

A Rare Splicing Mutation in the PROS1 Gene of a Korean Patient with Type I Hereditary Protein S Deficiency

Annals of clinical and laboratory science, 2011-09, Vol.41 (4), p.397-400

2011

Volltextzugriff (PDF)

Rituximab-induced acute thrombocytopenia: a case report and review of the literature

Medical oncology (Northwood, London, England), 2009-03, Vol.26 (1), p.45-48

2009

Volltextzugriff (PDF)

1 – 25 von 2.064

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.715)
Mit Volltextzugriff
(1.615)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.665)
Koreanisch
(392)
Japanisch
(200)
Deutsch
(4)
Spanisch
(2)
Portugiesisch
(1)

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(17)
... seit 30 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Trend and treatment patterns of aplastic anemia in Korea, pure red cell aplasia and myelodysplastic syndrome in Korea: a nation-wide analysis

Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study

Survey of Opioid Risk Tool Among Cancer Patients Receiving Opioid Analgesics

High level of pre-treatment C-reactive protein to albumin ratio predicts inferior prognosis in diffuse large B-cell lymphoma

Pretreatment C-reactive protein-to-albumin ratio predicts clinical outcomes in patients with peripheral T-cell lymphoma

The efficacy of pemetrexed as a third- or fourth-line therapy and the significance of thymidylate synthase expression in patients with advanced non-small cell lung cancer

Clinical impact of amphiregulin expression in patients with epidermal growth factor receptor (EGFR) wild‐type nonsmall cell lung cancer treated with EGFR‐tyrosine kinase inhibitors

Change of health-related profiles after Imatinib cessation in chronic phase chronic myeloid leukemia patients

Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea

Single cell proteogenomic sequencing identifies a relapse‐fated AML subclone carrying FLT3‐ITD with CN‐LOH at chr13q

Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)

High-Dose Ifosfamide as Second- or Third-Line Chemotherapy in Refractory Bone and Soft Tissue Sarcoma Patients

Lenalidomide for anemia correction in lower-risk del(5q) myelodysplastic syndrome patients of Asian ethnicity

Comparison of Therapeutic Outcomes Between Surgical Resection Followed By R-CHOP and R-CHOP Alone for Localized Primary Intestinal Diffuse Large B-cell Lymphoma

Can upfront systemic chemotherapy replace stereotactic radiosurgery or whole brain radiotherapy in the treatment of non-small cell lung cancer patients with asymptomatic brain metastases?

Real‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis

Anti-erythropoietin and anti-thrombopoietin antibodies induced after administration of recombinant human erythropoietin

Clinical significance of a serum CA15-3 surge and the usefulness of CA15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer

Irinotecan monotherapy as second-line treatment in advanced pancreatic cancer

Excision repair cross‐complementation group 1 (ERCC1) expression in advanced urothelial carcinoma patients receiving cisplatin‐based chemotherapy

Clinical impact of K-ras mutation in colorectal cancer patients treated with adjuvant FOLFOX

Prognostic role of insulin-like growth factor receptor-1 expression in small cell lung cancer

Outcomes of third-line docetaxel-based chemotherapy in advanced gastric cancer who failed previous oxaliplatin-based and irinotecan-based chemotherapies

A Rare Splicing Mutation in the PROS1 Gene of a Korean Patient with Type I Hereditary Protein S Deficiency

Rituximab-induced acute thrombocytopenia: a case report and review of the literature

Suchergebnisse filtern